Inflammation Controls Sensitivity of Human and Mouse Intestinal Epithelial Cells to Galectin-1

Journal of Cellular Physiology

Volumn 231, Issue 7, 2016, Pages 1575-1585

  Muglia, Cecilia I ^a   Papa Gobbi, Rodrigo ^a   Smaldini, Paola ^a   Orsini Delgado, María Lucía ^a   Candia, Martín ^a   Zanuzzi, Carolina ^b   Sambuelli, Alicia ^c   Rocca, Andrés ^c   Toscano, Marta A ^a   Rabinovich, Gabriel A ^a,d   Docena, Guillermo H ^a  

^a Universidad Nacional de Río Cuarto Consejo Nacional de Investigaciones Científicas y Técnicas   (Argentina)

^b FACULTAD DE CIENCIAS VETERINARIAS   (Argentina)

^c HOSPITAL DE GASTROENTEROLOGÍA DR CARLOS BONORINO UDAONDO   (Argentina)

^d UNIVERSIDAD DE BUENOS AIRES   (Argentina)

Author keywords

[No Author keywords available]

Indexed keywords

EPIDERMAL GROWTH FACTOR; GALECTIN 1; INTERLEUKIN 10; INTERLEUKIN 13; INTERLEUKIN 1BETA; INTERLEUKIN 25; INTERLEUKIN 5; THYMIC STROMAL LYMPHOPOIETIN; TRANSFORMING GROWTH FACTOR BETA1; TUMOR NECROSIS FACTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL FUNCTION; CELL VIABILITY; COLITIS; COLON; CONTROLLED STUDY; FOOD ALLERGY; HUMAN; HUMAN CELL; IN VIVO STUDY; INFLAMMATORY BOWEL DISEASE; INTESTINAL TISSUE; INTESTINE EPITHELIUM CELL; MICROENVIRONMENT; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN FUNCTION; PROTEIN SECRETION; SMALL INTESTINE; ANIMAL; GENETICS; INFLAMMATION; INTESTINE MUCOSA; METABOLISM; PATHOLOGY; TUMOR MICROENVIRONMENT;

ANIMALS; CELLULAR MICROENVIRONMENT; COLITIS; COLON; FOOD HYPERSENSITIVITY; GALECTIN 1; HUMANS; INFLAMMATION; INFLAMMATORY BOWEL DISEASES; INTESTINAL MUCOSA; MICE;

EID: 84952815526     PISSN: 00219541     EISSN: 10974652     Source Type: Journal    
DOI: 10.1002/jcp.25249     Document Type: Article

References (71)

1. An G, Wei B, Xia B, McDaniel JM, Ju T, Cummings RD, Braun J, Xia L. 2007. Increased susceptibility to colitis and colorectal tumors in mice lacking core 3-derived O-glycans. J Exp Med 204:417-429.
2. Bacigalupo ML, Manzi M, Espelt MV, Gentilini LD, Compagno D, Laderach DJ, Wolfenstein-Todel C, Rabinovich GA, Troncoso MF. 2015. Galectin-1 triggers epithelial-mesenchymal transition in human hepatocellular carcinoma cells. J Cell Physiol 230:1298-1309.
3. Barrow H, Rhodes JM, Yu L-G. 2011. The role of galectins in colorectal cancer progression. Int J Cancer 129:1-8.
4. Baumgart DC, Carding SR. 2007. Inflammatory bowel disease: Cause and immunobiology. Lancet 369:1627-1640.
5. Campbell BJ, Yu LG, Rhodes JM. 2001. Altered glycosylation in inflammatory bowel disease: A possible role in cancer development. Glycoconj J 18:851-858.
6. Cario E, Pdolsky DK. 2000. Differential alteration in intestinal epithelial cell expression of toll-like receptor 3 (TLR3) and TLR4 in inflammatory bowel disease. Infect Immun 68:7010-7017.
7. Ceska M. 1981. Radioimmunoassay of IgE using paper disks. Methods Enzymol 73:646-656.
8. Ciarlet M, Crawford SE, Estes MK. 2001. Differential infection of polarized epithelial cell lines by sialic acid-dependent and sialic acid-independent rotavirus strains. J Virol 75:11834-11850. Available at: http://www.pubmedcentral.nih.gov/articlerender.fc
9. Clark JA, Doelle SM, Halpern MD, Saunders TA, Holubec H, Dvorak K, Boitano SA, Dvorak B. 2006. Intestinal barrier failure during experimental necrotizing enterocolitis: Protective effect of EGF treatment. Am J Physiol Gastrointest Liver Physiol 91:G938-G949.
10. Croci DO, Cerliani JP, Dalotto-Moreno T, Méndez-Huergo SP, Mascanfroni ID, Dergan-Dylon S, Toscano MA, Caramelo JJ, García-Vallejo JJ, Ouyang J, Mesri EA, Junttila MR, Bais C, Shipp MA, Salatino M, Rabinovich GA. 2014. Glycosylation-dependent lectin-receptor interactions preserve angiogenesis in anti-VEGF refractory tumors. Cell 156:744-758.
11. Demetter P, Nagy N, Martin B, Mathieu A, Dumont P, Decaestecker C, Salmon I. 2008. The galectin family and digestive disease. J Pathol 215:1-12.
12. Di Sabatino A, Ciccocioppo R, Luinetti O, Ricevuti L, Morera R, Cifone MG, Solcia E, Corazza GR. 2003. Increased enterocyte apoptosis in inflamed areas of Crohn's disease. Dis Colon Rectum 46:1498-1507.
13. Elola MT, Wolfenstein-Todel C, Troncoso MF, Vasta GR, Rabinovich GA. 2007. Galectins: Matricellular glycan-binding proteins linking cell adhesion, migration, and survival. Cell Mol Life Sci 64:1679-1700.
14. Frol'ová L, Smetana K Jr, Borovská D, Kitanovicová A, Klimesová K, Janatková I, Malícková K, Lukás M, Drastich P, Benes Z, Tucková L, Manning JC, André S, Gabius HJ, Tlaskalová-Hogenová H. 2009. Detection of galectin-3 in patients with inflammatory bowel diseases: New serum marker of active forms of IBD? Inflamm Res 58:503-512.
15. Fu J, Wei B, Wen T, Johansson ME, Liu X, Bradford E, Thomsson KA, McGee S, Mansour L, Tong M, McDaniel JM, Sferra TJ, Turner JR, Chen H, Hansson GC, Braun J, Xia L. 2011. Loss of intestinal core 1-derived O-glycans causes spontaneous colitis in mice. J Clin Investig 121:1657-1666.
16. Gerner RR, Moschen AR, Tilg H. 2013. Targeting T and B lymphocytes in inflammatory bowel diseases: Lessons from clinical trials. Dig Dis 31:328-335.
17. Hardy H, Harris J, Lyon E, Beal J, Foey AD. 2013. Probiotics, prebiotics and immunomodulation of gut mucosal defences: Homeostasis and immunopathology. Nutrients 5:1869-1912.
18. Heller F, Florian P, Bojarski C, Richter J, Christ M, Hillenbrand B, Mankertz J, Gitter AH, Bürgel N, Fromm M, Zeitz M, Fuss I, Strober W, Schulzke JD. 2005. Interleukin-13 is the key effector Th2 cytokine in ulcerative colitis that affects epithelial tight junctions, apoptosis, and cell restitution. Gastroenterology 129:550-564.
19. Hittelet A, Legendre H, Nagy N, Bronckart Y, Pector JC, Salmon I, Yeaton P, Gabius HJ, Kiss R, Camby I. 2003. Upregulation of galectins-1 and -3 in human colon cancer and their role in regulating cell migration. J Int Cancer 103:370-379.
20. Hokama A, Mizoguchi E, Mizoguchi A. 2008. Roles of galectins in inflammatory bowel disease. World J Gastroenterol 14:5133-5137.
21. Ilarregui JM, Croci DO, Bianco GA, Toscano MA, Salatino M, Vermeulen ME, Geffner JR, Rabinovich GA. 2009. Tolerogenic signals delivered by dendritic cells to T cells through a galectin-1-driven immunoregulatory circuit involving interleukin 27 and interleukin. Nat Immunol 10:981-991.
22. Lee J, Lee EN, Kim EY, Park HJ, Chang CY, Jung DY, Choi SY, Lee SK, Lee KW, Kwon GY, Joh JW, Kim SJ. 2005. Administration of agonistic anti-4-1BB monoclonal antibody leads to the amelioration of inflammatory bowel disease. Immunol Lett 101:210-216.
23. Li MO, Flavell RA. 2008. Contextual regulation of inflammation: A duet by transforming growth factor-beta and interleukin-10. Immunity 28:468-476.
24. Lippert E, Gunckel M, Brenmoehl J, Bataille F, Falk W, Scholmerich J, Obermeier F, Rogler G. 2008. Regulation of galectin-3 function in mucosal fibroblasts: Potential role in mucosal inflammation. Clin Exp Immunol 152:285-297.
25. Livak KJ, Schmittgen TD. 2001. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 25:402-408.
26. Mahdavi J, Royer PJ, Sjölinder HS, Azimi S, Self T, Stoof J, Wheldon LM, Brännström K, Wilson R, Moreton J, Moir JW, Sihlbom C, Borén T, Jonsson AB, Soultanas P, Ala'Aldeen DA. 2013. Pro-inflammatory cytokines can act as intracellular modulators of commensal bacterial virulence. Open Biol 3:130048.
27. Makins R, Ballinger A. 2005. Interleukin-5 potentiates the growth response of Caco-2 cells to IGF-II: A role in colonic carcinogenesis complicating ulcerative colitis? Growth Horm IGF Res 15:215-222.
28. Maloy KJ, Powrie F. 2011. Intestinal homeostasis and its breakdown in inflammatory bowel disease. Nature 474:298-306.
29. Mizoguchi E, Mizoguchi A. 2007. Is the sugar always sweet in intestinal inflammation? Immunol Res 37:47-60.
30. Mowat AM. 1999. Basic mechanisms and clinical implications of oral tolerance. Curr Opin Gastroenterol 15:546-556.
31. Mowat AM, Parker LA, Beacock-Sharp H, Millington OR, Chirdo F. 2004. Oral tolerance: Overview and historical perspectives. Ann NY Acad Sci 1029:1-8.
32. Muglia C, Mercer N, Toscano MA, Schattner M, Pozner R, Cerliani JP, Gobbi RP, Rabinovich GA, Docena GH. 2011. The glycan-binding protein galectin-1 controls survival of epithelial cells along the crypt-villus axis of small intestine. Cell Death Dis 2:e163.
33. Munari F, Fassan M, Capitani N, Codolo G, Vila-Caballer M, Pizzi M, Rugge M, Della Bella C, Troilo A, D'Elios S, Baldari CT, D'Elios MM, de Bernard M. 2014. Cytokine BAFF released by Helicobacter pylori-infected macrophages triggers the Th17 response in human chronic gastritis. J Immunol 193:5584-5594.
34. Nalle SC, Turner JR. 2015. Intestinal barrier loss as a critical pathogenic link between inflammatory bowel disease and graft-versus-host disease. Mucosal Immunol 8:720-730.
35. Neurath MF, Fuss I, Kelsall BL, Stüber E, Strober W. 1995. Antibodies to interleukin 12 abrogate established experimental colitis in mice. J Exp Med 182:1281-1290.
36. Neurath MF, Finotto S, Fuss I, Boirivant M, Galle PR, Strober W. 2001. Regulation of T-cell apoptosis in inflammatory bowel disease: To die or not to die, that is the mucosal question. Trends Immunol 22:21-26.
37. Nikawa T, Ikemoto M, Kano M, Tokuoka K, Hirasaka K, Uehara S, Takatsu K, Rokutan K, Kishi K. 2001a. Impaired vitamin A-mediated mucosal IgA response in IL-5 receptor-knockout mice. Biochem Biophys Res Commun 285:546-549.
38. Nikawa T, Ikemoto M, Tokuoka K, Teshima S, Alpers DH, Masui Y, Kishi K, Rokutan K. 2001b. Interleukin-1beta enhances retinoic acid-mediated expression of bone-type alkaline phosphatase in rat IEC-6 cells. Am J Physio Gastrointest Liver Physiol 280:G510-G517.
39. Nita-Lazar M, Banerjee A, Feng C, Amin MN, Frieman MB, Chen WH, Cross AS, Wang LX, Vasta GR. 2015. Desialylation of airway epithelial cells during influenza virus infection enhances pneumococcal adhesion via galectin binding. Mol Immunol 65:1-16.
40. Nusrat A, Turner JR, Madara JL. 2000. Molecular physiology and pathophysiology of tight junctions. IV. Regulation of tight junctions by extracellular stimuli: Nutrients, cytokines, and immune cells. Am J Physio Gastrointest Liver Physiol 279:G851-G857.
41. O'Connell J, Bennett MW, Nally K, O'Sullivan GC, Collins JK, Shanahan F. 2000. Interferon-gamma sensitizes colonic epithelial cell lines to physiological and therapeutic inducers of colonocyte apoptosis. J Cell Physiol 185:331-338.
42. Olson TS. 2006. The primary defect in experimental ileitis originates from a nonhematopoietic source. J Exp Med 203:541-552.
43. Ose R, Oharaa O, Nagase T. 2012. Galectin-1 and galectin-3 mediate protocadherin-24-dependent membrane localization of β-catenin in colon cancer cell line HCT116. Curr Chem Genomics 6:18-26.
44. Paclik D, Lohse K, Wiedenmann B, Dignass AU, Sturm A. 2008. Galectin-2 and -4, but not galectin-1, promote intestinal epithelial wound healing in vitro through a TGF-beta-independent mechanism. Inflamm Bowel Dis 14:1366-1372.
45. Paclik D, Berndt U, Guzy C, Dankof A, Danese S, Holzloehner P, Rosewicz S, Wiedenmann B, Wittig BM, Dignass AU, Sturm A. 2008. Galectin-2 induces apoptosis of lamina propria T lymphocytes and ameliorates acute and chronic experimental colitis in mice. J Mol Med (Berl) 86:1395-1406.
46. Paclik D, Danese S, Berndt U, Wiedenmann B, Dignass A, Sturm A. 2008. Galectin-4 controls intestinal inflammation by selective regulation of peripheral and mucosal T cell apoptosis and cell cycle. PLoS ONE 3:e2629.
47. Planell N, Lozano JJ, Mora-Buch R, Masamunt MC, Jimeno M, Ordás I, Esteller M, Ricart E, Piqué JM, Panés J, Salas A. 2012. Transcriptional analysis of the intestinal mucosa of patients with ulcerative colitis in remission reveals lasting epithelial cell alterations. Gut 62:967-976.
48. Prasad S, Mingrino R, Kaukinen K, Hayes KL, Powell RM, MacDonald TT, Collins JE. 2005. Inflammatory processes have differential effects on claudins 2, 3 and 4 in colonic epithelial cells. Lab Invest 85:1139-1162.
49. Rabinovich GA, Liu FT, Hirashima M, Anderson A. 2007. An emerging role for galectins in tuning the immune response: Lessons from experimental models of inflammatory disease, autoimmunity and cancer. Scand J Immunol 66:143-158.
50. Rabinovich GA, Daly G, Dreja H, Tailor H, Riera CM, Hirabayashi J, Chernajovsky Y. 1999. Recombinant galectin-1 and its genetic delivery suppress collagen-induced arthritis via T cell apoptosis. J Exp Med 190:385-398.
51. Randall-Demllo S, Chieppa M, Eri R. 2013. Intestinal epithelium and autophagy: Partners in gut homeostasis. Front Immunol 4:301.
52. Santucci L, Fiorucci S, Rubinstein N, Mencarelli A, Palazzetti B, Federici B, Rabinovich GA, Morelli A. 2003. Galectin-1 suppresses experimental colitis in mice. Gastroenterology 124:1381-1394.
53. Siggers RH, Hackam DJ. 2011. The role of innate immune-stimulated epithelial apoptosis during gastrointestinal inflammatory diseases. Cell Mol Life Sci 68:3623-3634.
54. Smaldini P, Curciarello R, Candreva A, Rey MA, Fossati CA, Petruccelli S, Docena GH. 2012. In vivo evidence of cross-reactivity between cow's milk and soybean proteins in a mouse model of food allergy. Int Arch Allergy Immunol 158:335-346.
55. Starossom SC, Mascanfroni ID, Imitola J, Cao L, Raddassi K, Hernandez SF, Bassil R, Croci DO, Cerliani JP, Delacour D, Wang Y, Elyaman W, Khoury SJ, Rabinovich GA. 2012. Galectin-1 deactivates classically activated microglia and protects from inflammation-induced neurodegeneration. Immunity 37:249-263.
56. Strober W, Fuss IJ, Nakamura K, Kitani A. 2003. Recent advances in the understanding of the induction and regulation of mucosal inflammation. J Gastroenterol 38 Suppl:55-58.
57. Sturm A, de Souza HSP, Fiocchi C. 2008. Mucosal T cell proliferation and apoptosis in inflammatory bowel disease. Curr Drug Targets 9:381-387.
58. Suzuki T. 2013. Regulation of intestinal epithelial permeability by tight junctions. Cell Mol Life Sci 70:631-659.
59. Tang R, Yang G, Zhang S, Wu C, Chen M. 2014. Opposite effects of interferon regulatory factor 1 and osteopontin on the apoptosis of epithelial cells induced by TNF-α in inflammatory bowel disease. Inflamm Bowel Dis 20:1950-1961.
60. Thagia I, Shaw EJ, Smith E, Else KJ, Rigby RJ. 2014. Intestinal epithelial suppressor of cytokine signaling (SOCS) 3 enhances microbial induced inflammatory TNFα, contributing to epithelial barrier dysfunction. Am J Physiol Gastrointest Liver Physiol 308:G25-G31.
61. Toscano MA, Bianco GA, Ilarregui JM, Croci DO, Correale J, Hernandez JD, Zwirner NW, Poirier F, Riley EM, Baum LG, Rabinovich GA. 2007. Differential glycosylation of TH1, TH2 and TH-17 effector cells selectively regulates susceptibility to cell death. Nat Immunol 8:825-834.
62. Toscano MA, Commodaro AG, Ilarregui JM, Bianco GA, Liberman A, Serra HM, Hirabayashi J, Rizzo LV, Rabinovich GA. 2006. Galectin-1 suppresses autoimmune retinal disease by promoting concomitant Th2- and T regulatory-mediated anti-inflammatory responses. J Immunol 176:6323-6332.
63. Trautmann A, Schmid-Grendelmeier P, Krüger K, Crameri R, Akdis M, Akkaya A, Bröcker EB, Blaser K, Akdis CA. 2002. T cells and eosinophils cooperate in the induction of bronchial epithelial cell apoptosis in asthma. J Allergy Clin Immunol 109:329-337.
64. Van De Walle J, Hendrickx A, Romier B, Larondelle Y, Schneider YJ. 2010. Inflammatory parameters in Caco-2 cells: Effect of stimuli nature, concentration, combination and cell differentiation. Toxicol In Vitro 24:1441-1449.
65. Weber CR, Raleigh DR, Su L, Shen L, Sullivan EA, Wang Y, Turner JR. 2010. Epithelial myosin light chain kinase activation induces mucosal interleukin-13 expression to alter tight junction ion selectivity. J Biol Chem 285:12037-12046.
66. Williams IR. 2006. CCR6 and CCL20: Partners in intestinal immunity and lymphorganogenesis. Ann NY Acad Sci 1072:52-61.
67. Yamada T. ed. 2008. Textbook of gastroenterology. Oxford, UK: Blackwell Publishing Ltd.
68. Yeruva S, Ramadori G, Raddatz D. 2008. NF-kappaB-dependent synergistic regulation of CXCL10 gene expression by IL-1beta and IFN-gamma in human intestinal epithelial cell lines. Int J Colorectal Dis 23:305-317.
69. Zaph C, Du Y, Saenz SA, Nair MG, Perrigoue JG, Taylor BC, Troy AE, Kobuley DE, Kastelein RA, Cua DJ, Yu Y, Artis D. 2008. Commensal-dependent expression of IL-25 regulates the IL-23-IL-17 axis in the intestine. J Exp Med 205:2191-2198.
70. Zeuthen LH, Fink LN, Frokiaer H. 2008. Epithelial cells prime the immune response to an array of gut-derived commensals towards a tolerogenic phenotype through distinct actions of thymic stromal lymphopoietin and transforming growth factor-beta. Immunology 123:197-208.
71. Zhou P, Streutker C, Borojevic R, Wang Y, Croitoru K. 2004. IL-10 modulates intestinal damage and epithelial cell apoptosis in T cell-mediated enteropathy. Am J Physiol Gastrointest Liver Physiol 287:G599-G604.